Brief: Endo Announces Agreement For Paladin Pharma To Commercialize Wynzora Cream In Canada
Nov 15 (Reuters) - Endo Inc NDOI.PK :
* ENDO ANNOUNCES AGREEMENT FOR PALADIN PHARMA TO
COMMERCIALIZE
WYNZORA® CREAM IN CANADA
Source text: ID:nCNWBHSj7a
Further company coverage: NDOI.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Endo
See all newsBrief: Mallinckrodt, Endo Announce Planned Leadership Team For Merged Company
Brief: Endo To Report First Quarter 2025 Financial Results On May 7, 2025
Deals of the day-Mergers and acquisitions
Corrected: Deals of the day-Mergers and acquisitions
To Pay Endo $80.2 Million Termination Fee If Deal Is Terminated Under Certain Conditions